Presentation TCT 2012 TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease Presenter: Lamin King October 23, 2012
Presentation TCT 2012 Emotional Intelligence and Crucial Conversations Presenter: Jennifer Tremmel October 23, 2012
Presentation TCT 2012 TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction Presenter: Markus Schlaich October 23, 2012
Presentation TCT 2012 Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores? Presenter: Roxana Mehran October 23, 2012
Presentation TCT 2012 Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology Presenter: Robert Cottone October 23, 2012
Presentation TCT 2012 Antithrombotic Strategies in Patients on Chronic Oral Anticoagulation Presenter: Ramon Quesada October 23, 2012
Presentation TCT 2012 TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial Presenter: Jan-Henk Dambrink October 23, 2012
Presentation TCT 2012 Orsiro (BIOTRONIK) Program Update Presenter: Stephan Windecker October 23, 2012
Presentation TCT 2012 TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR... Presenter: Lamin King October 23, 2012